Ngm Biopharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ngm Biopharmaceuticals, Inc.

Patent Number:
Title:
Klotho-Beta For Use In Treating Cancer, Liver Disorders, Gallstones, Wasting Syndrome And Obesity-Related Diseases
Applicant:
Opposition Date:
Nov 20, 2018

Competitors of Ngm Biopharmaceuticals, Inc.

GENENTECH, INC.

Want to track Ngm Biopharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you